Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - influenzavirusoverfladeantigener (hæmagglutinin og neuraminidase) af stamme a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vacciner - aktiv immunisering mod h5n1-subtype af influenza a-virus. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

Tavegyl 1 mg/ml injektionsvæske, opløsning ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

tavegyl 1 mg/ml injektionsvæske, opløsning

glaxosmithkline consumer healthcare aps - clemastin - injektionsvæske, opløsning - 1 mg/ml

Tavegyl 1 mg tabletter ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

tavegyl 1 mg tabletter

glaxosmithkline consumer healthcare aps - clemastinfumarat - tabletter - 1 mg

Nicotinell Classic 2 mg medicinsk tyggegummi ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

nicotinell classic 2 mg medicinsk tyggegummi

glaxosmithkline consumer healthcare aps - nicotin - medicinsk tyggegummi - 2 mg

Nicotinell Classic 4 mg medicinsk tyggegummi ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

nicotinell classic 4 mg medicinsk tyggegummi

glaxosmithkline consumer healthcare aps - nicotin - medicinsk tyggegummi - 4 mg

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgængelige data på forskellige kombinationer).

Tekturna ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

tekturna

novartis europharm ltd. - aliskiren - forhøjet blodtryk - agenter, der virker på renin-angiotensinsystemet - behandling af essentiel hypertension.

Enviage ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

enviage

novartis europharm ltd. - aliskiren - forhøjet blodtryk - agenter, der virker på renin-angiotensinsystemet - behandling af essentiel hypertension.

Arzerra ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

arzerra

novartis europharm ltd - ofatumumab - leukæmi, lymfocytisk, kronisk, b-celle - monoklonale antistoffer - tidligere ubehandlet kronisk lymfatisk leukæmi (cll): arzerra i kombination med chlorambucil eller bendamustine er indiceret til behandling af patienter med cll, som ikke har modtaget forudgående behandling, og som ikke er berettiget til fludarabine-baseret terapi. recidiverende cll: arzerra er indiceret i kombination med fludarabine og cyclophosphamid til behandling af voksne patienter med recidiverende cll. refraktær cll: arzerra er indiceret til behandling af cll hos patienter, som er refraktære over for fludarabine og alemtuzumab.

DuoTrav ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

duotrav

novartis europharm limited - travoprost, timolol - glaucoma, open-angle; ocular hypertension - oftalmologiske - reduktion af intraokulært tryk (iop) hos voksne patienter med åbenvinklet glaukom eller okulær hypertension, som ikke er tilstrækkeligt lydhør over for aktuelle beta-blokkere eller prostaglandinanaloger.